Abstract
Triple-negative breast cancer (TNBC) is an invasive, aggressive, and recurrent tumor subclassification among the female population. Due to the non-expression of important hormone receptors, there are difficulties both in the prognosis and in the treatment of patients diagnosed with TNBC. Chemotherapy, in the absence of targeted therapies, is the most used method in these cases. Seeking be…